Novavax, Inc. (NVAX)
10.46
+0.38
(+3.72%)
USD |
NASDAQ |
Mar 17, 10:45
Novavax Market Cap : 1.703B for March 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 154.61B |
| Moderna, Inc. | 21.71B |
| Merck & Co., Inc. | 288.08B |
| Intellia Therapeutics, Inc. | 1.604B |
| Recursion Pharmaceuticals, Inc. | 1.806B |
Market Cap Related Metrics
| PE Ratio | 4.392 |
| PS Ratio | 1.588 |
| Price | 10.46 |
| Earnings Yield | 22.77% |
| Operating PE Ratio | 3.166 |
| Normalized PE Ratio | 3.526 |